MaxCyte, Inc. (MXCT)
NASDAQ: MXCT · Real-Time Price · USD
1.610
+0.010 (0.63%)
Dec 26, 2025, 4:00 PM EST - Market closed
MaxCyte Market Cap
MaxCyte has a market cap or net worth of $171.75 million as of December 29, 2025. Its market cap has decreased by -61.22% in one year.
Market Cap
171.75M
Enterprise Value
84.18M
1-Year Change
-61.22%
Ranking
Category
Stock Price
$1.61
Market Cap Chart
Since the IPO on March 10, 2021, MaxCyte's market cap has decreased from $494.67M to $171.75M, a decrease of -65.28%. That is a compound annual growth rate of -19.78%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 26, 2025 | 171.75M | -60.94% |
| Dec 31, 2024 | 439.69M | -9.93% |
| Dec 29, 2023 | 488.14M | -12.55% |
| Dec 30, 2022 | 558.17M | -45.87% |
| Dec 31, 2021 | 1.03B | 108.47% |
| Mar 10, 2021 | 494.67M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 965.00B |
| Johnson & Johnson | 500.24B |
| AbbVie | 406.46B |
| UnitedHealth Group | 300.58B |
| AstraZeneca | 286.29B |
| Novartis AG | 267.64B |
| Merck & Co. | 265.03B |
| Novo Nordisk | 232.28B |